InvestorsHub Logo

blueyedcatch

02/14/18 2:26 PM

#54398 RE: mpreorder #54396

So far no side effects worth discussing. You can get the flu all by yourself,and die from it these days. Adxs has the best results ever with the smallest amount of side effects in correlation. The cost of production at around 5 bucks a dose will have ample room for sweet margins.

hdwrsft

02/14/18 2:26 PM

#54399 RE: mpreorder #54396

Points to a slam dunk.

The proxy-n-sheeples meeting will soon pass....and I think a permanent CEO is likely to be announced shortly after.

...and then, we'll see if the double-digits returns heading into ASCO.

Donjayouworry

02/14/18 2:43 PM

#54405 RE: mpreorder #54396

I love that AF called it a Hail Mary. He knows shorts still need to cover.

gajj

02/14/18 2:50 PM

#54409 RE: mpreorder #54396

demonstrated need, low cost, effective, minimal side effects, production is scaleable

heldnova

02/14/18 6:42 PM

#54447 RE: mpreorder #54396

Has the EU ever approved a drug based on comparison to historical standard of care results without a placebo arm as a comparator.?

Rick

mypekeispooped

02/19/18 11:31 AM

#55223 RE: mpreorder #54396

I also found this interesting:

"In particular, early dialogue and timely preparation for
conditional applications could support prompt assessment and generation of the required post-authorisation data, and further efforts could target those therapeutic areas that so far have
not been successful in applying this regulatory tool."

I believe we've had quite a bit of early dialogue.